Intelligence
Latest
Fundraising
Alternative investment management company Pollen Street Capital (Pollen Street) has closed PSC Fund IV, which will focus on growth investments in European financial and business services.
EXIT
Current Health, a leading care-at-home technology platform that brings together remote patient monitoring, telehealth, and patient engagement into a single solution for healthcare organisations, has become Europe’s second-largest digital health exit following its acquisition by US-based consumer electronics retailer Best Buy – after announcing a value of approximately USD400 million in yesterday’s earnings call.
FUND LAUNCH
HRL Morrison & Co (Morrison & Co) has held the first close of a new open-ended global infrastructure fund, the Morrison & Co Infrastructure Partnership (MCO IP), securing more than USD3 billion in fund commitments and co-investment capital from anchor investors.
RESEARCH
The UK and US are driving forward the rapid growth of the global healthtech sector, with latest data from London & Partners and Dealroom.co showing a record USD51.3 billion has been pumped into startups already this year, up 280 per cent on 2016 levels.
SURVEY
The coming six months will bring increasingly stiff competition for more private equity deals at higher prices that demand larger fund sizes, going beyond the significant rebound that had been reported six months ago, according to the autumn 2021 edition of the DealCloud Dealmaker Pulse Survey Report by Intapp.
PARTNER FEATURE
Private equity professionals are facing a more specialised and competitive market than ever. GPs are reviewing more deal opportunities, conducting more due diligence, and giving more fundraising pitches than ever before. Whether it’s identifying potential investments, or explaining their strategy to investors, PE professionals’ need for instantly actionable sources of deep intelligence and analysis is outstripping the ability of legacy data to keep up.
FUNDRAISING
HSBC Asset Management has held the final closing of its second directly-managed secondaries fund, Private Equity Opportunities II (PE Opps II), which launched in August 2021.
INVESTMENT
Lyre’s, a non-alcoholic spirits brand, has completed a GBP20 million funding round, valuing the business at GBP270 million (post money), extending its position as the most valuable brand in the no/low alcohol category worldwide.
DEAL
Sika is to acquire MBCC Group, the former BASF Construction Chemicals, from an affiliate of Lone Star Funds, a global private equity firm, for a consideration of EUR5.2 billion.
INTERVIEW
When venture capital investor Kate Bingham was appointed to lead the UK’s coronavirus vaccine procurement effort in May 2020, Prime Minister Boris Johnson tasked her with delivering “speed, not perfection”.
By December that year, the UK had approved its first Covid-19 vaccine, developed by Pfizer/BioNTech.
Since then, 80 per cent of the UK population over the age of 12 have received at least one vaccine, and the jabs are working “much better than anyone expected”.
“To get any vaccine from identification of pathogen through to a vaccine, the quickest historically has been five years, but that was 50 years ago,” says
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
